Gene therapy and graft modification

Current Opinion in Organ Transplantation

Volumn 6, Issue 4, 2001, Pages 343-347

  Zamir, Gideon ^a   Olthoff, Kim M ^a   Shaked, Abraham ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HEME OXYGENASE 1; HLA A2 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

BIOMEDICAL TECHNOLOGY ASSESSMENT; BIOSAFETY; BONE MARROW CELL; CELL DEATH; CELL TRANSPLANTATION; CLINICAL TRIAL; CONVALESCENCE; CRYOPRESERVATION; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PROTECTION; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SHUTTLE VECTOR;

EID: 0035687271     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200112000-00013     Document Type: Review

References (55)

1. Viral vectors for gene transfer: A review of their use in the treatment of human diseases
2. Transfer and expression of foreign genes in mammalian cells
3. Viral vectors for gene transfer into antigen presenting cells
4. Viral vectors for gene therapy
5. Adenoviral vectors for liver-directed gene therapy
6. Improvements in adenoviral vector technology: Overcoming barriers for gene therapy
7. Adenovirus-mediated gene transfer in the transplant setting. I. Conditions for expression of transferred genes in cold-preserved hepatocytes
8. Adenovirus-mediated gene transfer to liver grafts: An improved method to maximize infectivity
9. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB
10. Immune responses to adenovirus and adeno-associated virus in humans
11. Biology of E1-deleted adenovirus vectors in nonhuman primate muscle
12. Adenovirus vectors for gene delivery
13. Adeno-associated virus-mediated gene delivery
14. Lentiviral vectors
15. Persistent, therapeutically relevant levels of human granulocyte colony-stimulating factor in mice after systemic delivery of adeno-associated virus vectors
16. Engineering tissue-specific expression of a recombinant adenovirus: Selective transgene transcription in the pancreas using the amylase promoter
17. Exogenous control of cardiac gene therapy: Evidence of regulated myocardial transgene expression after adenovirus and adeno-associated virus transfer of expression cassettes containing corticosteroid response element promoters
18. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer
19. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells
20. Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen
21. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumor rejection
22. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta
23. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival
24. Adenovirus-mediated gene therapy to liver grafts: Successful gene transfer by donor pretreatment
25. Adenovirus-mediated gene transfer in the transplant setting. II. Successful expression of transferred cDNA in syngeneic liver grafts
26. Adenovirus-mediated gene transfer in the transplant setting. Part III. Variables affecting gene transfer in liver grafts
27. Gene transfer and models of gene therapy for the myocardium
28. Transbronchial gene transfer of endothelial nitric oxide synthase to transplanted lungs
29. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival
30. Retroviral-mediated gene transfer into rat experimental liver transplant
31. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft
32. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses
33. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig
34. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression
35. Adenovirus-mediated gene transfer in the transplant setting: Early events after orthotopic transplantation of liver allografts expressing TGF-beta 1
36. Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity
37. DNA-liposome versus adenoviral mediated gene transfer of transforming growth factor beta 1 in vascularized cardiac allografts: Differential sensitivity of CD4+ and CD8+ T cells to transforming growth factor beta 1
38. Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: A rodent model of IL-4-induced hepatitis
39. Prolongation of liver allograft survival after interleukin-10 gene transduction 24-48 hours before donation
40. Allograft transduction of IL-10 prolongs survival following orthotopic liver transplantation
41. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats
42. Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene
43. Pattern of alloimmune response in second same donor allograft after induction of tolerance using CTLA4Ig
44. Modified AdCTLA-4 vector blocks alloimmune response in vitro
45. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLAIg-gene
46. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig
47. Local production of CTLA-Ig by adenoviral-mediated gene transfer to the panreas induces permanent allograft survival and donor-specifc tolerance
48. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism
49. Tolerance to solid organ transplants through transfer of MHC class II genes
50. Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers
51. Delivery of Cu/Zn-superoxide dismutase gene with a viral vector minimizes liver injury and improves survival after liver transplantation in the rat
52. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation
53. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury
54. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene
55. Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation